Apeiron Bioenergy closes equity investment in Mitsui Chemicals, poised to capture exponential growth in bioenergy market with pan-Asian presence
– Mitsui Chemicals has invested to support Apeiron’s pan-Asian expansion
– Strategic partnership with Mitsui Chemicals will strengthen Apeiron’s regional scalability and commitment to net zero emissions
SINGAPORE, Aug. 31, 2022 – (ACN Newswire) — Apeiron Bioenergy has successfully closed an equity financing round from Mitsui Chemicals. The funds will help Apeiron increase its capacity to collect waste-based feedstocks in Asian markets and position the company for exponential growth in the face of growing demand for renewable feedstocks for advanced biofuels such as fuel. sustainable aviation (SAF).
|From left to right: Chris Chen, Managing Director, Apeiron Bioenergy; Tadashi Yoshino, Managing Director, Mitsui Chemicals|
According to the International Energy Agency, global demand for renewable diesel is expected to more than double, or 11 billion litres, over the next five years. The demand stems primarily from government regulations in the US and EU, as established in the decarbonization targets by COP26. However, planned capacity is expected to significantly exceed domestic feedstock supply, and production must keep pace with the climate emergency – where will the additional feedstock come from?
Apeiron Bioenergy, a leading integrated player and solutions provider in the field of bioenergy, collects and processes a range of renewable feedstocks, including waste cooking oil (UCO) and oil mill effluent of palm (POME), acts as a key exporter in an ever-expanding Asian market. . Over the past 15 years, Apeiron Bioenergy has established its presence in more than 10 countries and collected more than 500 million liters of UCO between 2017 and 2021, offsetting approximately 1.5 million tons of carbon emissions.
“Zero carbon emissions is one of our strategic goals by 2050. As one of Japan’s leading chemical companies, our investment in Apeiron is our way of contributing to solving future global environmental problems,” said said Tadashi Yoshino, Managing Director, General Manager, Mitsui Chemicals. “Apeiron Bioenergy has a proven track record of aggregating renewable raw materials and streamlining the supply chain across Asia. We are excited to invest in the business as it aligns with our sustainability goals.
Apeiron Bioenergy’s access to diverse feedstock sources and networks and its relationships with downstream customers means it is in an excellent position to access and supply downstream by-products for Mitsui Chemicals to help it achieve its net zero goals.
With Mitsui Chemicals serving as a strategic investor, Apeiron Bioenergy will be well positioned to meet the substantial increase in demand for biofuels by increasing its capacity at collection points and processing facilities through organic and inorganic growth. The company actively seeks to acquire or collaborate with local collectors of sustainable raw materials in Asian markets.
“Tackling bioenergy supply chain issues across Asia requires a collaborative, community-driven approach – our experienced leadership team has proven that we can solve supply chain inefficiencies. supply through our multicultural and multi-jurisdictional strategy,” said Chris Chen, Managing Director of Apeiron Bioenergy. . “We will increase our collection capacity, working closely with our downstream partners to address the broader sustainability issue of reducing carbon emissions in land, sea and air transport spaces.”
For all media inquiries, please contact:
Financial Public Relations
Such. : +65-6438-2990
Email: [email protected]
Source: Apeiron Bioenergy
Copyright 2022 ACN Newswire. All rights reserved.